These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27574445)

  • 1. New utility of an old marker: serum low-density lipoprotein predicts histopathological response of neoadjuvant chemotherapy in locally advanced gastric cancer.
    Zhou JC; Guo JF; Teng RY; Wang QC; Wang J; Wei Q; Li ZD; Shen JG; Wang LB
    Onco Targets Ther; 2016; 9():5041-7. PubMed ID: 27574445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital histopathological images of biopsy predict response to neoadjuvant chemotherapy for locally advanced gastric cancer.
    Zhou Z; Ren Y; Zhang Z; Guan T; Wang Z; Chen W; Luo T; Li G
    Gastric Cancer; 2023 Sep; 26(5):734-742. PubMed ID: 37322381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
    Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction model of objective response after neoadjuvant chemotherapy in patients with locally advanced gastric cancer.
    Xu W; Fan Z; Wang L; He C; Ni Z; Hua Z; Zhu Z; Yang Z; Zheng Y; Feng R; Yan C; Li C; Yao X; Chen M; Yan M; Zhu Z; Liu W
    Am J Transl Res; 2021; 13(3):1568-1579. PubMed ID: 33841680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer.
    Zhou J; Shen J; Seifer BJ; Jiang S; Wang J; Xiong H; Xie L; Wang L; Sui X
    Oncotarget; 2017 May; 8(18):30477-30494. PubMed ID: 27802185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor response evaluation after neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: a prospective, multi-center cohort study.
    Achilli P; De Martini P; Ceresoli M; Mari GM; Costanzi A; Maggioni D; Pugliese R; Ferrari G
    J Gastrointest Oncol; 2017 Dec; 8(6):1018-1025. PubMed ID: 29299362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival.
    Wang RX; Chen S; Huang L; Zhou Y; Shao ZM
    Oncologist; 2019 Jun; 24(6):753-761. PubMed ID: 30126858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy-induced severe neutropenia is associated with histopathological response and survival in locally advanced gastric cancer.
    Wu C; Wang T; Zhou H; Zhang X; Guo C; Chen Y; Zhao D
    Transl Cancer Res; 2020 Jan; 9(1):280-293. PubMed ID: 35117182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally advanced gastric cancer: total iodine uptake to predict the response of primary lesion to neoadjuvant chemotherapy.
    Gao X; Zhang Y; Yuan F; Ding B; Ma Q; Yang W; Yan J; Du L; Wang B; Yan F; Sedlmair M; Pan Z; Zhang H
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2207-2218. PubMed ID: 30094537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between Lin28 and the chemotherapy response of gastric cancer.
    Teng RY; Zhou JC; Jiang ZN; Xu CY; Li ZD; Wang QC; Xu CP; Guo JF; Shen JG; Wang LB
    Onco Targets Ther; 2013; 6():1341-5. PubMed ID: 24098084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker analysis to predict the pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer: An exploratory biomarker study of COMPASS, a randomized phase II trial.
    Oshima T; Yoshikawa T; Miyagi Y; Morita S; Yamamoto M; Tanabe K; Nishikawa K; Ito Y; Matsui T; Kimura Y; Yokose T; Hiroshima Y; Aoyama T; Hayashi T; Ogata T; Cho H; Rino Y; Masuda M; Tsuburaya A; Sakamoto J
    Oncotarget; 2020 Jul; 11(30):2906-2918. PubMed ID: 32774771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer.
    Wang LB; Teng RY; Jiang ZN; Hu WX; Dong MJ; Yuan XM; Chen WJ; Jin M; Shen JG
    J Surg Oncol; 2012 Mar; 105(3):293-6. PubMed ID: 21882201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XPA expression is a predictive marker of the effectiveness of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.
    Wada T; Fukuda T; Shimomura M; Inoue Y; Kawanishi M; Tasaka R; Yasui T; Ikeda K; Sumi T
    Oncol Lett; 2018 Mar; 15(3):3766-3771. PubMed ID: 29556276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a clinical nomogram for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer.
    Liu B; Xu YJ; Chu FR; Sun G; Zhao GD; Wang SZ
    World J Gastrointest Surg; 2024 Feb; 16(2):396-408. PubMed ID: 38463346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of neoadjuvant chemotherapy on nutritional status of locally advanced gastric cancer].
    Deng G; Qu J; Zhai S; Shi Y; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):331-335. PubMed ID: 29577223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
    Xu X; Zheng G; Zhang T; Zhao Y; Zheng Z
    Cancer Chemother Pharmacol; 2019 Sep; 84(3):635-646. PubMed ID: 31230156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?
    Bozkaya Y; Özdemir NY; Sezer S; Köstek O; Demirci NS; Yazıcı O; Erdem GU; Eren T; Zengin N
    Cancer Biomark; 2018; 22(1):143-149. PubMed ID: 29562501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
    Sylvie L; Susanne B; Katja O
    Recent Results Cancer Res; 2012; 196():269-89. PubMed ID: 23129380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
    Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
    Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UCP2 expression may represent a predictive marker of neoadjuvant chemotherapy effectiveness for locally advanced uterine cervical cancer.
    Imai K; Fukuda T; Wada T; Kawanishi M; Tasaka R; Yasui T; Sumi T
    Oncol Lett; 2017 Jul; 14(1):951-957. PubMed ID: 28693257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.